Topic

Virginia

A collection of 501 issues

If Tegsedi (Inotersen) Isn't Approved by Aetna CVS Health in Virginia: Formulary Alternatives & Exception Paths

Answer Box: Your Path Forward When Tegsedi Is Denied If Aetna CVS Health denies Tegsedi (inotersen) in Virginia, you have clear alternatives and appeal options. Onpattro (patisiran) is typically the required first-line treatment under Aetna's step therapy policy. After documented failure or intolerance to Onpattro, you can request

How Long Does It Take to Get Trikafta Approved by Cigna in Virginia? Complete Timeline and Appeals Guide

Answer Box: Getting Trikafta Approved by Cigna in Virginia Standard Cigna prior authorization for Trikafta takes up to 5 business days in Virginia, or 2 calendar days for expedited requests. You'll need F508del mutation documentation, CF specialist prescription, and complete clinical records. If denied, you have 180 days

How to Get Entresto (Sacubitril/Valsartan) Covered by Cigna in Virginia: Forms, Appeals, and Step Therapy Rights

Answer Box: Getting Entresto Covered by Cigna in Virginia Entresto (sacubitril/valsartan) requires prior authorization from Cigna, with step therapy requiring documented ACE inhibitor or ARB trial failure. Submit your PA request via CoverMyMeds or fax to 1-866-873-8279 with heart failure diagnosis, LVEF results, and medication history. If denied, file

How to Get Zanzalintinib (XL092) Covered by Aetna CVS Health in Virginia: Appeals, Forms & Timelines

Answer Box: Getting Zanzalintinib (XL092) Covered by Aetna CVS Health in Virginia Zanzalintinib (XL092) is investigational and typically denied by Aetna CVS Health unless part of a clinical trial or compassionate use program. Your fastest path: 1) Have your doctor request a formulary exception with detailed medical necessity documentation, 2)

How to Get Filspari (sparsentan) Covered by Aetna (CVS Health) in Virginia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Filspari (sparsentan) Covered by Aetna (CVS Health) in Virginia Eligibility: Adults with biopsy-confirmed primary IgA nephropathy, proteinuria ≥1g/day, and failed ACE/ARB therapy. Fastest path: Have your nephrologist submit prior authorization with REMS enrollment, quarterly LFT plan, and step therapy documentation. Start today: Call Aetna member

How to Get Arikayce (Amikacin Liposome Inhalation) Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Arikayce Covered by Blue Cross Blue Shield in Virginia Arikayce (amikacin liposome inhalation) requires prior authorization from Blue Cross Blue Shield in Virginia for MAC lung disease. To get coverage, you need documented refractory MAC after 6+ months of standard multidrug therapy with persistent positive cultures. Submit

How to Get StrataGraft Approved by Aetna CVS Health in Virginia: Complete Prior Authorization & Appeals Guide

Quick Answer: Getting StrataGraft Covered by Aetna CVS Health in Virginia StrataGraft requires prior authorization from Aetna CVS Health and must be billed as a facility procedure (HCPCS J7353), not through pharmacy benefits. You'll need comprehensive burn documentation, surgical consultation, and medical necessity justification. If denied, Virginia offers

How to Get Carbaglu (Carglumic Acid) Covered by UnitedHealthcare in Virginia: Complete PA Guide with Appeals Process

Quick Answer: Getting Carbaglu Covered by UnitedHealthcare in Virginia Yes, you can get Carbaglu (carglumic acid) covered by UnitedHealthcare in Virginia if you have confirmed NAGS deficiency. UnitedHealthcare requires prior authorization with genetic/enzyme testing, elevated ammonia levels, and specialist documentation. If denied, Virginia's external review process via

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by UnitedHealthcare in Virginia: Complete Guide to Prior Authorization, Appeals, and State Protections

Answer Box: Getting Besponsa Covered in Virginia Besponsa (inotuzumab ozogamicin) requires prior authorization from UnitedHealthcare in Virginia. Your oncologist must document CD22-positive B-cell ALL, failed prior chemotherapy, and a hepatic monitoring plan. If denied, Virginia offers strong consumer protections: you can appeal internally (180 days), then request external review through

Get Xospata (Gilteritinib) Covered by Blue Cross Blue Shield in Virginia: ICD-10 Codes, Prior Auth Forms, and Appeals Guide

Answer Box: Getting Xospata Covered in Virginia To get Xospata (gilteritinib) covered by Blue Cross Blue Shield in Virginia, you'll need: (1) confirmed FLT3-mutated relapsed/refractory AML diagnosis with proper ICD-10 coding (C92.02 for relapsed AML), (2) prior authorization submission through Anthem's Availity portal with